US2020131555A1PendingUtilityA1
Incorporation of unnatural nucleotides and methods thereof
Est. expiryJul 11, 2037(~10.9 yrs left)· nominal 20-yr term from priority
Inventors:Jerod PtacinCarolina E. CaffaroHans AerniYorke ZhangEmil C. FischerAaron W. FeldmanVivian T. DienFloyd E. Romesberg
C12N 15/90C12N 15/113C12N 9/93C12P 21/02C12Y 601/01026C12N 15/11
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.
Claims
exact text as granted — not AI-modified1 .- 23 . (canceled)
24 . An E. coli cell comprising:
(a) a nucleoside triphosphate transporter from Phaeodactylum tricornutum; (b) an mRNA comprising an unnatural base comprising a structure selected from
(c) a tRNA comprising an unnatural base comprising a structure selected from
and
(d) an aminoacyl tRNA synthetase derived from an organism selected from the group consisting of Methanosarcina barkeri and Methanococcus jannaschii.
25 . The E. coli cell of claim 24 , wherein the cell further comprises an oligonucleotide encoding the mRNA.
26 . The E. coli cell of claim 24 , wherein the cell further comprises an oligonucleotide encoding the tRNA.
27 . The E. coli cell of claim 24 , wherein the cell further comprises an oligonucleotide encoding the aminoacyl tRNA synthetase.
28 . The E. coli cell of claim 24 , wherein the cell further comprises a single oligonucleotide encoding the mRNA and the tRNA.
29 . The E. coli cell of claim 24 , wherein the cell further comprises a single oligonucleotide encoding the mRNA, the tRNA, and the aminoacyl tRNA synthetase.
30 . The E. coli cell of claim 24 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base.
31 . The E. coli cell of claim 30 , wherein the mRNA comprises the codon AXC.
32 . The E. coli cell of claim 31 , wherein the unnatural base comprises the structure
33 . The E. coli cell of claim 31 , wherein the unnatural base comprises the structure
34 . The E. coli cell of claim 30 , wherein the mRNA comprises the codon GXC.
35 . The E. coli cell of claim 34 , wherein the unnatural base comprises the structure
36 . The E. coli cell of claim 34 , wherein the unnatural base comprises the structure
37 . The E. coli cell of claim 24 , wherein the aminoacyl tRNA synthetase is derived from Methanosarcina barkeri.
38 . The E. coli cell of claim 36 , wherein the mRNA comprises an unnatural base comprising the structure
and the tRNA comprises an unnatural base comprising the structure
39 . The E. coli cell of claim 37 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base.
40 . The E. coli cell of claim 24 , wherein the aminoacyl tRNA synthetase is derived from Methanococcus jannaschii.
41 . The E. coli cell of claim 39 , wherein the mRNA comprises an unnatural base comprising the structure
and the tRNA comprises an unnatural base comprising the structure
42 . The E. coli cell of claim 40 , wherein the mRNA comprises one or more codons selected from AXC and GXC, wherein X is the unnatural base.
43 . The E. coli cell of claim 24 , wherein the tRNA is derived from an organism selected from the group consisting of Methanosarcina barkeri and Methanococcus jannaschii.Join the waitlist — get patent alerts
Track US2020131555A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.